The cancer proteomic landscape and the HUPO Cancer Proteome Project

The Human Cancer Proteome Project (Cancer-HPP) is an international initiative organized by HUPO whose key objective is to decipher the human cancer proteome through a coordinated effort by cancer proteome researchers around the world. The ultimate goal is to map the entire human cancer proteome to d...

Descripción completa

Detalles Bibliográficos
Autores principales: Jimenez, Connie R., Zhang, Hui, Kinsinger, Christopher R., Nice, Edouard C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785860/
https://www.ncbi.nlm.nih.gov/pubmed/29416445
http://dx.doi.org/10.1186/s12014-018-9180-6
Descripción
Sumario:The Human Cancer Proteome Project (Cancer-HPP) is an international initiative organized by HUPO whose key objective is to decipher the human cancer proteome through a coordinated effort by cancer proteome researchers around the world. The ultimate goal is to map the entire human cancer proteome to disclose tumor biology and drive improved diagnostics, treatment and management of cancer. Here we report the progress in the cancer proteomics field to date, and discuss future proteomic developments that will be needed to optimally delineate cancer phenotypes and advance the molecular characterization of this significant disease that is one of the leading causes of death worldwide. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12014-018-9180-6) contains supplementary material, which is available to authorized users.

Ejemplares similares